Kymera Therapeutics to Announce KT-579 Phase 1 Results Oct. 29
Kymera Therapeutics said it will announce KT-579 Phase 1 healthy volunteer trial results on October 29, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
Kymera Therapeutics to Announce KT-579 Phase 1 Trial Results October 29
Kymera Therapeutics said it will announce results from the KT-579 Phase 1 healthy volunteer trial on October 29, 2026.